RK

Rajesh Kumar Shingari

Active Director Director DIN 01776513
DIN 01776513 First appointment Jul 2008 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2008
Shareholding value •••• Premium profile

About Rajesh Kumar Shingari

Data last updated:

Rajesh Kumar Shingari is a Director at Thor Drugs Private Limited (since 2008). The company operates in Pharma. Thor Drugs Private Limited reported revenue of ₹37.4 Lakh (FY 2025).

DIN 01776513
Primary Designation Director
Industry Pharma
First Appointment 23 Jul 2008
Oldest Company Age 18 yrs
Largest company Thor Drugs Private Limited · ₹37.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Thor Drugs Private Limited U24239GJ2008PTC054549
Director23 Jul 20082008₹37.4 Lakh (FY 2025)Active

Board colleagues of Rajesh Kumar Shingari

Directorship timeline

Open interactive timeline →
Thor Drugs Private Limited
Premium access

Shareholding and investment profile for Rajesh Kumar Shingari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Kumar Shingari

Rajesh Kumar Shingari currently holds 1 directorship: Thor Drugs Private Limited (Director, since 23 Jul 2008, revenue ₹37.4 Lakh (FY 2025)).

Rajesh Kumar Shingari was first appointed on 23 Jul 2008 as Director at Thor Drugs Private Limited.

The current boards of Rajesh Kumar Shingari's companies include Hans Raj Kalra (Thor Drugs Private Limited), Kavita Gupta (Thor Drugs Private Limited), Mandeep Singh Dhamo (Thor Drugs Private Limited), Neha Gupta (Thor Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available